WASHINGTON - First treatment for Huntington’s has been approved by Federal regulators on Friday in the United, a rare inherited disease that causes uncontrolled movements, corrosion of mental capabilities, ultimately and death.

Drug Xenazine, will not cure Huntington and also have some serious side effects, such as elevation of suicidal behavior. Though, it provides relief from chief disabling symptom of Huntington’s those are the jerky and involuntary movements (also known as chorea).

“A lot of patients won’t go out because they are embarrassed by those movements,” said Dr. Frederick J. Marshall, who led the clinical study that proves drug’s effectiveness. “Suppressing those movements means a lot to people with Huntington’s disease.”